"Designing Growth Strategies is in our DNA"

U.S. Prescription Drugs Market Size, Share & COVID-19 Impact Analysis, By Product Type (Generic Drugs, Orphan Drugs, and Other Prescription Drugs), By Therapy Area (Oncology, Central Nervous System, Vaccines, Immunosuppressants, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, and Online Pharmacies), and Country Forecast, 2023-2030

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI108971

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases, 2022
    2. Pipeline Analysis
    3. Key Industry Developments
    4. Recent Product Launches, By Key Players
    5. Impact of COVID-19 on the Market
  5. U.S. Prescription Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Generics
      2. Orphan
      3. Other Prescription Drugs
    2. Market Analysis, Insights and Forecast – By Therapy Area
      1. Oncology
      2. Central Nervous System
      3. Vaccines
      4. Immunosuppressants
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Novartis AG
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      2. Pfizer, Inc.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability
      3. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability
      4. Sanofi
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability
      5. Johnson & Johnson Services, Inc.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability
      6. Merck & Co., Inc.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability
      7. AbbVie, Inc.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability
      8. GlaxoSmithKline plc.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability
      9. AstraZeneca
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability
      10. CELGENE CORPORATION (BRISTOL-MYERS SQUIBB COMPANY)
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Key Diseases, 2022
    2. Pipeline Analysis
    3. Key Industry Developments
    4. Recent Product Launches, By Key Players
    5. Impact of COVID-19 on the Market
  5. U.S. Prescription Drugs Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Product Type
      1. Generics
      2. Orphan
      3. Other Prescription Drugs
    2. Market Analysis, Insights and Forecast – By Therapy Area
      1. Oncology
      2. Central Nervous System
      3. Vaccines
      4. Immunosuppressants
      5. Others
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies & Drug Stores
      3. Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. Novartis AG
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability)
      2. Pfizer, Inc.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability
      3. F. Hoffmann-La Roche Ltd.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability
      4. Sanofi
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability
      5. Johnson & Johnson Services, Inc.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability
      6. Merck & Co., Inc.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability
      7. AbbVie, Inc.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability
      8. GlaxoSmithKline plc.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability
      9. AstraZeneca
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability
      10. CELGENE CORPORATION (BRISTOL-MYERS SQUIBB COMPANY)
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent developments
        5. strategies
        6. financials (based on availability
Read Less

Figure 1: U.S. Prescription Drugs Market Revenue Breakdown (USD billion, %) by Product Type, 2022 & 2030

Figure 2: U.S. Prescription Drugs Market Value Share (%), by Product Type, 2022 & 2030

Figure 3: U.S. Prescription Drugs Market Value Share (%), by Therapy Area, 2022 & 2030

Figure 4: U.S. Prescription Drugs Market Value Share (%), by Distribution Channel, 2022 & 2030

Figure 5: U.S. Prescription Drugs Market Share (%), By Company, 2022

Table 1: U.S. Prescription Drugs Market Revenue (USD billion) Forecast, by Product Type, 2019-2030

Table 2: U.S. Prescription Drugs Market Revenue (USD billion) Forecast, by Therapy Area, 2019-2030

Table 3: U.S. Prescription Drugs Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2030

Table 4: U.S. Prescription Drugs Market Revenue (USD billion) Forecast, by Region, 2019-2030

U.S. Prescription Drugs Market
  • 2019-2030
  • 2022
  • 2019-2021
  • 70
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports